CellSeed Inc. Logo

CellSeed Inc.

Develops cell sheet products, culture equipment, and offers contract manufacturing services.

7776 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
江東区青海2−5−10テレコムセンタービル15F
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CellSeed Inc. is a regenerative medicine company focused on the commercialization of its proprietary 'cell sheet engineering' technology, an innovative therapeutic approach originating in Japan. The company's core business involves the research, development, and manufacturing of cell sheet-based products to treat diseases and disorders. In addition to its therapeutic pipeline, CellSeed develops and sells specialized cell culture equipment and provides contracted development and manufacturing services for cell sheets. The company aims to deliver its novel medical treatments to patients globally, leveraging its expertise in cell culture and production to advance the field of regenerative medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:48
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-08-14 08:47
Interim Report
半期報告書-第25期(2025/01/01-2025/12/31)
Japanese 176.2 KB
2025-03-27 06:07
Post-Annual General Meeting Information
臨時報告書
Japanese 25.6 KB
2025-03-26 08:00
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 08:00
Governance Information
内部統制報告書-第24期(2024/01/01-2024/12/31)
Japanese 21.2 KB
2025-03-26 07:59
Annual Report
有価証券報告書-第24期(2024/01/01-2024/12/31)
Japanese 827.2 KB
2024-08-14 08:15
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-08-14 08:14
Interim Report
半期報告書-第24期(2024/01/01-2024/06/30)
Japanese 181.4 KB
2024-05-15 08:19
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-05-15 08:19
Quarterly Report
四半期報告書-第24期第1四半期(2024/01/01-2024/03/31)
Japanese 145.1 KB
2024-03-28 07:11
Post-Annual General Meeting Information
臨時報告書
Japanese 22.0 KB
2024-03-28 07:08
Registration Form
確認書
Japanese 8.1 KB
2024-03-28 07:07
Governance Information
内部統制報告書-第23期(2023/01/01-2023/12/31)
Japanese 22.2 KB
2024-03-28 07:04
Annual Report
有価証券報告書-第23期(2023/01/01-2023/12/31)
Japanese 875.2 KB
2023-11-14 08:37
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all CellSeed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CellSeed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Labocanna Spolka Akcyjna Logo
Cultivates and distributes medical marijuana and cannabinoid products for clinical and consumer use.
Poland LCN
Labomar Logo
A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.
Italy LBM
Laboratorio Farmaceutico Erfo Logo
Full-service contract manufacturer of private label supplements and medical devices.
Italy ERFO
Laboratorio Reig Jofre S.A. Logo
A pharmaceutical company making essential health products accessible in over 70 countries.
Spain RJF
Laboratorios Farmaceuticos Rovi S.A. Logo
Integrated pharma firm developing prescription drugs and offering contract manufacturing services.
Spain ROVI
Lavipharm S.A. Logo
Develops & distributes Rx/OTC medicines, supplements & cosmetics for key therapeutic areas.
Greece LAVI
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.
Israel LCTX
Lipigon Pharmaceuticals AB Logo
Develops novel drugs for lipid metabolism disorders to reduce cardiovascular disease risk.
Sweden LPGO
Lipum AB Logo
Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.
Sweden LIPUM
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN

Talk to a Data Expert

Have a question? We'll get back to you promptly.